Last reviewed · How we verify
NCT03624738
Femorofemoral Bypass in Redo Cardiac Surgery
NA trial testing Procedure in Heart Valve Diseases in 40 participants. Status unknown.
28 March 2019
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 17 January 2019 |
| Primary completion | 28 March 2019 |
| Estimated completion | 30 March 2019 |
Drugs / interventions tested
- Procedure
Conditions studied
- Heart Valve Diseases — all drugs for Heart Valve Diseases →
Sponsor
Assiut University
Who can join
Adults 25 to 65, any sex, with Heart Valve Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Redo cardiac surgery are becoming more common with a patient population at greater risk. Sternal re-entry poses the hazard of probable injury to vital structures. To minimize the risk associated with sternal re-entry, the investigators adopted the method of establishing femoral artery-femoral vein cardiopulmonary bypass (CPB).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03624738
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Procedure
Trials testing the same drug.
- NCT04096755 — Targeted Metabolic Profiling in Deep Vein Thrombosis · unknown
- NCT03300882 — PREDICT Cytomegalovirus (CMV) · completed
- NCT03309436 — Effects of Clomiphene Citrate Ovulation Induction on Frozen Embryo Transfer · Phase 4 · unknown
- NCT03135600 — The Influence of Running to ACL Deficiency · NA · completed
- NCT03135613 — Kinematics of Knees of Patients With Tumor Around Knee After Microwave Ablation With Plate Internal Fixation · NA · unknown
Other recruiting trials for Heart Valve Diseases
Currently open trials in the same condition.
- NCT07390903 — GLS in Difficult CPB Weaning · recruiting
- NCT07099859 — Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Unde · Phase 4 · recruiting
- NCT06215378 — Antagonization of Heparin With Protamine Sulfate After TAVI · Phase 3 · recruiting
- NCT06445231 — Echocardiography in Nursing Home · NA · recruiting
- NCT06569602 — Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU) · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03624738 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 9 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03624738.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing